Video
Author(s):
The nephrologist at Mayo Clinic provided insight on new data showing elevated extracellular vesicles of neurovascular origin in women with a history of severe preeclampsia years after pregnancy. [WATCH TIME: 4 minutes]
WATCH TIME: 4 minutes
“When we studied [extracellular vesicles] in the blood of these women, they are expressing a higher rate of amyloid-ß compared with the normotensive pregnancies only. Knowing its role in Alzheimer disease, we were amazed by these findings ourselves.”
To better understand the long-term neuroimmunological effects of preeclampsia (PE), a pregnancy-specific hypertensive disorder, a recent study matched 40 women with a history of normotensive pregnancies to 40 age- and parity-matched women with mild (n = 33) and severe PE (n = 7). Blood-borne circulating extracellular vesicles (EVs) derived from neurovascular cellular activation were determined by standardized digital flow cytometry, while plasma concentration of amyloid-ß was measured by ELISA.
Findings indicated that women with a severe history of PE had a significantly higher concentration of amyloid-ß carrying EVs compared with controls (P = .003), as well as those with a history of mild PE (P = .037). Additionally, EVs positive for the markers of blood-brain barrier-endothelial damage and inflammatory coagulation pathway activator were significantly higher in severe PE cases vs controls (P = .008 and P = .002, respectively). Senior investigator Vesna Garovic, MD, PhD, sat down with NeurologyLive® to detail these findings.
Garovic, a nephrologist at Mayo Clinic, provided insight on the previous studies that led to this research, the biggest take-home points from the new data, and the next steps in further building on these findings.
Click here for more coverage of AAIC 2022.
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.